The Diagnosis Of Depression In Alzheimer's Disease
Funder
National Health and Medical Research Council
Funding Amount
$361,000.00
Summary
During the next 3 decades the number of persons older than 85 years will more than double, and the health care need of this burgeoning population are assuming greater importance. Among the most significant but often overlooked conditions in the elderly is depression, which is associated with marked disability, functional decline, risk of hospitalization, diminished quality of life, caregiver burden, increased service utilization, and mortality from comorbid medical conditions or suicide. The Wor ....During the next 3 decades the number of persons older than 85 years will more than double, and the health care need of this burgeoning population are assuming greater importance. Among the most significant but often overlooked conditions in the elderly is depression, which is associated with marked disability, functional decline, risk of hospitalization, diminished quality of life, caregiver burden, increased service utilization, and mortality from comorbid medical conditions or suicide. The World Health Organization predicts that by 2020 depression will be second only to heart disease as a cause of disability and premature death in established market economies. Depression is missed in approximately half of all elderly persons with mood disorder, and this frequency is certainly higher among individuals with dementia. The strategy to diagnose depression in dementia needs to be revised. Patients' reports are often unreliable due to memory problems and lack of full insight into their mood and behavioural changes. Caregivers may overestimate patients' symptoms of depression, especially when they themselves are depressed and overburdened, and clinicians' diagnoses are sometimes based on biased information and short observation periods. The situation in nursing homes is even worse, and there is a shortage of studies on how to diagnose depression in institutionalised patients with dementia. Using specific instruments to assess mood, behaviour and cognition we will develop valid and reliable criteria to diagnose depression in the different stages of dementia, and for patients living in different settings. This will facilitate the early recognition and adequate treatment of depression in individuals with dementia, it will greatly improve patient's quality of life, and will have a positive impact on caregivers' psychological well-being.Read moreRead less
Development Of A New Surgical-guidance Tool For Intra-operative Tumour Margin Assessment In Breast Cancer
Funder
National Health and Medical Research Council
Funding Amount
$557,982.00
Summary
One third of breast cancer patients undergoing breast conserving surgery have insufficient tissue removed, resulting in an increased risk of recurrence. We have developed a high resolution optical imaging probe with the potential to detect small areas of cancer. It could be used to help guide the surgeon to remove all cancerous tissue from the patient. This grant will allow us to develop the probe to a stage that it can be used during surgery, and perform the world’s first clinical scans.
Development Of Microscope-in-a-needle Devices For Improved Clinical Diagnostics
Funder
National Health and Medical Research Council
Funding Amount
$327,746.00
Summary
We have developed a new high-resolution optical imaging technology. The unique aspect of our research has been to redesign the imaging probe, miniaturising it to a few hundred microns in diameter, and encase it in a hypodermic needle – a ‘microscope-in-a-needle’. We are developing specific imaging probes to aid in the assessment of lung disease; the diagnosis of liver disease; and integrated into a brain biopsy needle to enable safer brain biopsies.
Advances in positron emission tomography now allow specific pathological features of many brain diseases such as Alzheimer's disease to be measured with a brain scan during life. This Fellowship will assist Professor Rowe and his team in their world leading work on new PET scanning techniques to improve diagnosis and assist the development of treatment for Alzheimer's and other degenerative diseases of the brain.
The Role Of Interferon Signalling In The Regulation Of Stroke
Funder
National Health and Medical Research Council
Funding Amount
$620,381.00
Summary
This project focuses on the role that inflammation plays in the progression of the type of neural injury seen in stroke victims. This project targets a specific pathway that is thought to be involved in the regulation of general inflammation but has not been greatly investigated in terms of the neural injury seen in stroke. Understanding the actions of this pathway may lead to future therapies that can be used to prime the brain to react in a positive way to stroke.